S:t Olofsgatan 11A
Uppsala 753 21
Sweden
46 7 25 02 10 10
https://www.dicotpharma.com
Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 3
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Ms. Elin Trampe | Chief Executive Officer | 1,18M | N/A | 1980 |
Dr. Jarl Wikberg Ph.D. | Founder & Chief Scientific Officer | 67,75k | N/A | N/A |
Mr. Bjorn Petersson | Chief Financial Officer | N/A | N/A | 1961 |
Dr. Mats Silvander Ph.D. | Chief Technical Officer | N/A | N/A | N/A |
Ms. Charlotta Gauffin | Chief Scientific Officer | N/A | N/A | 1971 |
Ms. Julie Silber | Director of Investor Relations | N/A | N/A | N/A |
Ms. Gabriela Urquilla | Director of Communications | N/A | N/A | N/A |
Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It is developing LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden.
Dicot Pharma ABs ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.